EDRH
DOVA

Edmond de Rothschild Holding’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Edmond de Rothschild Holding’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-12,000
Closed -$346K – 848
2017
Q4 		$346K Buy
+12,000
New +$329K 0.01% 414

Other funds holding DOVA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return

Edmond de Rothschild Holding's DOVA Position: Q1 2018 in Review

Edmond de Rothschild Holding sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q1 2018, closing a stake of 12,000 shares — an estimated $346K sold.

Edmond de Rothschild Holding first reported a position in DOVA in Q4 2017 and held it in 1 quarter. The position peaked at $346K in Q4 2017. 55 funds tracked by Wall St. Rank hold DOVA as of Q1 2018.

  • Edmond de Rothschild Holding reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 12,000 Dova Pharmaceuticals, Inc. Common Stock shares in Q1 2018, an estimated $346K.
  • Edmond de Rothschild Holding first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Edmond de Rothschild Holding's Dova Pharmaceuticals, Inc. Common Stock position peaked at $346K in Q4 2017.
  • 55 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q1 2018.

Based on Edmond de Rothschild Holding's 13F filing for Q1 2018, filed 15 May 2018.